Current Clinical Trials

Participation in any clinical trial being conducted at a BluePearl Veterinary Partners hospital requires a referral from your family veterinarian. If you and your veterinarian are interested in learning more about enrollment in one of our active trials, please have your family veterinarian contact the doctor conducting the study. We are sorry, but we cannot take calls directly from pet owners about our clinical trials.

CANINE STUDIES

Florida

Study: Cruciate Repair

Summary
BluePearl Veterinary Partners – Florida is participating in a funded clinical trial for evaluation of post-op pain management. Cruciate repair and associated diagnostics and procedures provided.

Dogs that meet any of the following criteria may not participate in this study:

1. Invasive surgical procedures within 14 days prior to enrollment
2. Undergone procedures that would interfere with an accurate assessment of pain
3. Concurrent painful condition other than the presenting condition, which could interfere with pain assessments
4. Treated with topical or systemic anti-inflammatory products such as NSAIDS within 14 days prior to enrollment
5. Treated with short-acting (systemic or local) corticosteriods within 30 days
6. Received alternate forms of pain relief (i.e. chiropractic manipulation, dry or wet acupuncture, acupressure, etc.) within 30 days prior to enrollment
7. Received polysulfated glycosaminoglycans within 14 days prior to surgery
8. Known to be fractious causing difficulty in collecting clinical specimens and giving oral medications or injections
9. Cannot be adequately examined because of aggressive or frightened behavior
10. Known to have intolerances to anesthetics.

To Participate
**Our participant roster is currently full. However, we will accept more cases in April. ** Participation in any clinical trial being conducted at a BluePearl Veterinary Partners hospital requires a referral from your family veterinarian. If you and your veterinarian are interested in learning more about enrollment in this clinical trial, please have your family veterinarian contact Dr. Teresa Lightfoot 813-933-8944.

Minnesota

Study: Cruciate Repair

Summary
BluePearl Veterinary Partners – Minnesota is participating in a funded clinical trial for evaluation of post-op pain management. Cruciate repair and associated diagnostics and procedures provided.

Dogs that will be excluded from consideration of this study have had any of one of the following items:

1. Invasive surgical procedures within 14 days prior to enrollment
2. Undergone procedures that would interfere with an accurate assessment of pain
3. Concurrent painful condition other than the presenting condition, which could interfere with pain assessments
4. Treated with topical or systemic anti-inflammatory products such as NSAIDS within 14 days prior to enrollment
5. Treated with short-acting (systemic or local) corticosteriods within 30 days
6. Received alternate forms of pain relief (i.e. chiropractic manipulation, dry or wet acupuncture, acupressure, etc.) within 30 days prior to enrollment
7. Received polysulfated glycosaminoglycans within 14 days prior to surgery
8. Known to be fractious causing difficulty in collecting clinical specimens and giving oral medications or injections
9. Cannot be adequately examined because of aggressive or frightened behavior
10. Known to have intolerances to anesthetics.

To Participate
Information on how to participate is coming soon. Please check back.

New York

Study: Oncology Appetite and Quality-of-Life Survey

Summary
BluePearl Veterinary Partners – New York is conducting a survey of pet owners whose dogs have been or are being treated for cancer and the veterinary oncologists providing their medical care. The goal is to determine the dogs’ frequency, severity, and duration of reduced appetite, gastroenteritis and altered quality of life.  

Eligibility Requirements 

1. Dogs with any cancer (excluding lymphoma and hemangiosarcoma) receiving chemotherapy (no prednisone)
2. Dogs with lymphoma receiving chemotherapy (no prednisone)
3. Dogs with lymphoma receiving chemotherapy with concurrent prednisone
4. Dogs with hemangiosarcoma receiving doxorubicin chemotherapy following splenectomy (no prednisone)
5. Dogs with any cancer receiving toceranib (no prednisone)
6. Dogs with any cancer that is in complete remission (no prednisone) and is not receiving any therapy that is likely to negatively impact appetite (melanoma vaccine, routine follow-up on long-term cases that previously received chemotherapy or radiation therapy).

Funding
$100 is provided to the client for completion of this two-week survey. 

Participation
Participation in any clinical trial being conducted at a BluePearl Veterinary Partners hospital requires a referral from your family veterinarian. If you and your veterinarian are interested in learning more about enrollment in this clinical trial, please have your family veterinarian contact Dr. Joshua Lachowicz at 212-767-0099.

Tennessee

Study: Cruciate Repair

Summary
BluePearl Veterinary Partners – Florida is participating in a funded clinical trial for evaluation of post-op pain management. Cruciate repair and associated diagnostics and procedures provided.

Dogs that will be excluded from consideration of this study have had any of one of the following items:

1. Invasive surgical procedures within 14 days prior to enrollment
2. Undergone procedures that would interfere with an accurate assessment of pain
3. Concurrent painful condition other than the presenting condition, which could interfere with pain assessments
4. Treated with topical or systemic anti-inflammatory products such as NSAIDS within 14 days prior to enrollment
5. Treated with short-acting (systemic or local) corticosteriods within 30 days
6. Received alternate forms of pain relief (i.e. chiropractic manipulation, dry or wet acupuncture, acupressure, etc.) within 30 days prior to enrollment
7. Received polysulfated glycosaminoglycans within 14 days prior to surgery
8. Known to be fractious causing difficulty in collecting clinical specimens and giving oral medications or injections
9. Cannot be adequately examined because of aggressive or frightened behavior
10. Known to have intolerances to anesthetics.

To Participate
Information on how to participate is coming soon. Please check back.

FELINE STUDIES

Kansas

Study:  Novel Oral Medication for the Treatment of Diabetes Mellitus in Cats

Summary
BluePearl Veterinary Specialists – Kansas is participating in a funded clinical trial for the treatment of diabetes mellitus in cats. The goal of this trial is to investigate the safety and potential effectiveness of a novel therapeutic agent.

Eligibility Requirements

  • Cats must weigh greater than 5 lbs
  • Cats must have not received corticosteroids within the previous 60 days
  • Cats must otherwise be in good health / no ketones
  • Cats must not have received insulin therapy for greater than 4 days
  • Cats must be amenable to receiving oral medications at home
  • Owners must be able to present their cat for 10 hour glucose curves on days 1, 7, 14, 30 and 45 days.

Funding
All blood tests and evaluations as well as the test medication are free of charge to the owner. Veterinarians will receive a fee of $150 in the client’s name for each cat that completes the study. Owners will be provided Prozinc insulin to start after the study. A limited number of cats will be enrolled.

To Participate
Participation in any clinical trial being conducted at a BluePearl Veterinary Partners hospital requires a referral from your family veterinarian. If you and your veterinarian are interested in learning more about enrollment in this clinical trial, please have your family veterinarian contact contact Beth Rogers, Cynthia Caudle, or Dr. Jeff Dennis at 913.642.9563.